Source LDPath provides end-to-end cellular pathology services, with a core focus on introducing a ground-breaking integration of digital pathology and AI technology to transform the clinical diagnostic process.
The integration of this digital platform is able to streamline digital reporting, frame an efficient workflow, expand bandwidth for data storage and improve administrative measures across the entire diagnostic journey. Source LDPath’s digital integration model enables a drastic reduction in patient turnaround times from sample receipt to reporting, and improved patient care. In executing this medical transformation, the integration of digital pathology services will be critical for both service providers and NHS trusts.
Source BioScience also offers services in genomics, precision medicine and stability storage.
T: +44 (0) 115 973 9012
E: [email protected]
W: www.sourcebioscience.com